States representing about 84% of Medicaid beneficiaries are participating in an initiative that enables the U.S. government ...

The CDMO, which has been owned by different private investors over the last decade, will use the funds to broaden its ...

Sino Biopharmaceuticals plans to pay up to $950.9 million to acquire LaNova Medicines, which previously licensed drugs to ...

NHS England agreed to reimburse Vertex's newest cystic fibrosis medicine. Meanwhile, Merck advanced a once-monthly PrEP pill ...

Baxdrostat, which AstraZeneca acquired in a 2023 buyout of CinCor Pharma, could become a new treatment for people whose ...

While the CRL derails a near-term clearance, one analyst described the rejection as more of “a speed bump to approval, rather ...

Positive late-stage study results position the company to file for clearance of what could be the first narcolepsy drug that ...

From clinical trials to commercialization, pharma organizations are under immense pressure to reduce time to market.

Current operations chief Renee Gala will succeed Bruce Cozadd at Jazz. Meanwhile, Nuclidium raised about $99 million to ...

The main patent for Ohtuvayre, the COPD drug at the heart of Verona’s $10 billion sale, expired in 2020. For Merck to make ...

The company said it was “surprised” by the decision, which followed the ouster of cell and gene therapy officials from the ...

Preliminary quarterly sales figures for Vykat surpassed Wall Street estimates, but shares fell on concerns the company may ...